Numerous types of microcrystalline cellulose (MCC) are available on the market for a variety of uses in pharmaceutical industry. They can be used as adsorbents, anti-adherents, binders/diluents and tablet disintegrants (1). On the industrial scale, MCC is obtained by hydrolysis of wood and cotton cellulose using dilute mineral acids. The treated pulp is then rinsed and spray-dried with or without an additional process step such as milling. Cellulose from different sources differs in the properties such as crystallinity, moisture content, surface area, porous structure, molecular mass. These properties can be also affected by the conditions of hydrolysis. Preparations of MCC from materials other than wood and cotton (e.g., water hyacinth, coconut shells, wheat and rice straws, etc.) have also been reported (2). Influence of some commercially available types of microcrystalline cellulose (MCC) on the stability of certain active pharmaceutical ingredients (APIs), when in contact, has been investigated. Two structurally similar APIs, perindopril erbumine (PER) and enalapril maleate (EM), both well-known angiotensin-converting enzyme inhibitors were used. The main properties of an MCC that could determine the stability for each API were measured and correlated to the stability of these two APIs in binary mixtures. The stability of these APIs differed when in contact with different types of MCC. The dominant properties of MCC from one manufacturer were surface features that influenced the stability of PER and acidity that influenced the stability of EM. In the case of MCC from other manufacturers, unbound water was stability determining for both substances.